3FII

Crystal structure of Clostridium botulinum neurotoxin serotype F catalytic domain with an inhibitor (inh2)

3FII の概要

• エントリーDOI: 10.2210/pdb3fii/pdb
• 関連するPDBエントリー: 2A8A 2A97 3FIE
• 分子名称: BOTULINUM NEUROTOXIN TYPE F, fragment of Vesicle-associated membrane protein 2, ZINC ION, ... (4 entities in total)
• 機能のキーワード: clostridium botulinum, bont f, vamp, inhibitor, complex structure, acetylation, cell junction, hydrolase, toxin-protein transport complex, toxin/protein transport
• 由来する生物種: Clostridium botulinum; 詳細
• 細胞内の位置: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Single-pass type IV membrane protein: P63027
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 52621.26

構造登録者

Agarwal, R.,Swaminathan, S. (登録日: 2008-12-11, 公開日: 2009-06-23, 最終更新日: 2023-11-22)

主引用文献

Agarwal, R.,Schmidt, J.J.,Stafford, R.G.,Swaminathan, S.
Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
Nat.Struct.Mol.Biol., 16:789-794, 2009

PubMed Abstract: Clostridium botulinum neurotoxins (BoNTs) cleave neuronal proteins responsible for neurotransmitter release, causing the neuroparalytic disease botulism. BoNT serotypes B, D, F and G cleave and inactivate vesicle-associated membrane protein (VAMP), each at a unique peptide bond. The specificity of BoNTs depends on the mode of substrate recognition. We have investigated the mechanism of substrate recognition of BoNT F by determining the crystal structures of its complex with two substrate-based inhibitors, VAMP 22-58/Gln58D-cysteine and 27-58/Gln58D-cysteine. The inhibitors bind to BoNT F in the canonical direction (as seen for BoNTs A and E substrates) but are positioned specifically via three major exosites away from the active site. The cysteine sulfur of the inhibitors interacts with the zinc and exists as sulfinic acid in the inhibitor VAMP 27-58/Gln58D-cysteine. Arg133 and Arg171, which form part of two separate exosites, are crucial for substrate binding and catalysis.

PubMed: 19543288
DOI: 10.1038/nsmb.1626

実験手法

X-RAY DIFFRACTION (2.17 Å)